Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cellebrite DI Ltd. - Ordinary Shares (NQ: CLBT )

22.18 -0.34 (-1.51%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,241,801
Open 22.76
Bid (Size) 22.40 (5)
Ask (Size) 22.80 (17)
Prev. Close 22.52
Today's Range 22.05 - 22.91
52wk Range 7.910 - 22.63
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cellebrite Announces Participation in the UBS Global Technology and AI Conference
From Cellebrite DI Ltd
Via GlobeNewswire
Cellebrite and Relativity Deliver Solutions to Transform the Mobile Data Collection Landscape
Cellebrite Endpoint Inspector Solutions are now generally available within RelativityOne 
From Cellebrite DI Ltd
Via GlobeNewswire

Performance

YTD
+163.11%
+163.11%
1 Month
+12.47%
+12.47%
3 Month
+28.21%
+28.21%
6 Month
+89.90%
+89.90%
1 Year
+153.49%
+153.49%

More News

Read More
CORRECTION: Cellebrite Announces Third-Quarter 2024 Results
From Cellebrite DI Ltd
Via GlobeNewswire
Yossi Carmil to Step Down as CEO After Nearly 20 Years
From Cellebrite DI Ltd
Via GlobeNewswire
Cellebrite Announces Third-Quarter 2024 Results
From Cellebrite DI Ltd
Via GlobeNewswire
Cellebrite Announces Tim Tebow as Keynote Speaker for Inaugural Case-to-Closure (C2C) User Summit 2025
From Cellebrite DI Ltd
Via GlobeNewswire
Cellebrite to Report Third-Quarter 2024 Financial Results on November 6, 2024
From Cellebrite DI Ltd
Via GlobeNewswire
Cellebrite Patents its Remote Mobile Collection Capabilities for Businesses
From Cellebrite DI Ltd
Via GlobeNewswire
Cellebrite Announces Results of Completed Redemption of All Outstanding Warrants
From Cellebrite DI Ltd
Via GlobeNewswire
Cellebrite Enhances Investigative Analytics Solution with Amazon Web Services (AWS)
From Cellebrite DI Ltd; Amazon Web Services (AWS)
Via GlobeNewswire
Mailbag With Motley Fool Co-Founder Tom Gardner
Via The Motley Fool
Cellebrite Announces "Redemption Fair Market Value" in Connection with Redemption of All Outstanding Warrants
From Cellebrite DI Ltd
Via GlobeNewswire
H&R Block Posts Upbeat Earnings, Joins Alibaba Group, CI&T And Other Big Stocks Moving Higher On Friday
Via Benzinga
CLBT Stock Earnings: Cellebrite DI Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Cellebrite Announces Second-Quarter 2024 Results
From Cellebrite DI Ltd
Via GlobeNewswire
Cellebrite Announces Redemption of All Outstanding Warrants
From Cellebrite DI Ltd
Via GlobeNewswire
Cellebrite Appoints Tech Veteran Troy K. Richardson to Board of Directors
From Cellebrite DI Ltd
Via GlobeNewswire
Cellebrite Appoints Renowned Cybersecurity Expert Sigalit Shavit as Chief Information Officer
From Cellebrite DI Ltd
Via GlobeNewswire
Will The Nasdaq 100's Relief Rally Hold Or Is A Sharp Decline Inevitable?
Via Talk Markets
Topics Stocks
Exposures US Equities
FBI Reportedly Used Israel-Based Security Firm's Unreleased Technology To Crack Trump Shooter's Phone
Via Benzinga
Topics Government
Exposures Criminal Legal Political
Cellebrite Advances Plans to Transform and Elevate its Strategic Relationship with the U.S. Federal Government
From Cellebrite DI Ltd
Via GlobeNewswire
Cellebrite to Report Second-Quarter 2024 Financial Results on August 15, 2024
From Cellebrite DI Ltd
Via GlobeNewswire
Cellebrite Announces Availability of Industry-Leading Endpoint Inspector SaaS Solution on Amazon Web Services Marketplace
From Cellebrite DI Ltd
Via GlobeNewswire
Why Software Company Cellebrite Shares Are Up Today
Via Benzinga
CLBT Stock Earnings: Cellebrite DI Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.